Secondary parkinsonism (G21)
ICD-10 Index
Diseases of the nervous system (G00–G99)
Extrapyramidal and movement disorders (G20-G26)
- G21 - Secondary parkinsonism NON-BILLABLE CODE
- G21.0 - Malignant neuroleptic syndrome BILLABLE CODE
- G21.1 - Other drug-induced secondary parkinsonism NON-BILLABLE CODE
- G21.11 - Neuroleptic induced parkinsonism BILLABLE CODE
- G21.19 - Other drug induced secondary parkinsonism BILLABLE CODE
- G21.2 - Secondary parkinsonism due to other external agents BILLABLE CODE
- G21.3 - Postencephalitic parkinsonism BILLABLE CODE
- G21.4 - Vascular parkinsonism BILLABLE CODE
- G21.8 - Other secondary parkinsonism BILLABLE CODE
- G21.9 - Secondary parkinsonism, unspecified BILLABLE CODE
Secondary parkinsonism (G21)
Clinical Information for Secondary parkinsonism (G21)
Neuroleptic Malignant Syndrome - A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)